Study Design Analyst, Evinova

Study Design Analyst, Evinova Are you ready to be part of the future of healthcare? Can you think big, be bold, and harness the power of digital and AI to tackle longstanding life sciences challenges? Then Evinova, a new health tech business part of the AstraZeneca Group might be for you! Accountabilities: In this role on our Customer Delivery team, you'll lead the design and deployment of Evinova's platform for clinical trials. You'll translate complex clinical protocols into system configuration, manage the design process, and ensure the successful implementation of our Unified Trial Platform. Your expertise will shape the future of clinical studies, making healthcare more efficient and accessible. Essential Skills/Experience: Bachelor's degree with 4-7 years of experience in building and configuring digital solutions for clinical trials; 3 years of experience specifically with eCOA systems. Proven senior stakeholder management skills, including negotiation, collaboration, and interpersonal leadership abilities. Demonstrable experience of gathering and translating business requirements into technical specifications and configurations for digital solutions used in clinical trials. Strong understanding of clinical trial processes and regulations with respect to study design. Experience with connected devices (e.g. PEF, oxygen monitors) and integrating with other clinical systems, such as IVRS, EDC, data lakes, etc. Excellent analytical, problem-solving, and communication skills with the ability to interact effectively with team members and customers at all levels. Desirable Skills/Experience: Master's degree in relevant discipline. Experience from Healthcare and Life Sciences, preferably with clinical trials. Experience of working in a global organization with complex/geographical context. Experience of working in a regulated environment, ideally of delivering GxP and SaMD solutions. Why Evinova (AstraZeneca)? Evinova draws on AstraZeneca's deep experience developing novel therapeutics, informed by insights from thousands of patients and clinical researchers. Together, we can accelerate the delivery of life-changing medicines, improve the design and delivery of clinical trials for better patient experiences and outcomes, and think more holistically about patient care before, during, and after treatment. We know that regulators, healthcare professionals, and care teams at clinical trial sites do not want a fragmented approach. They do not want a future where every pharmaceutical company provides its own, different digital solutions. They want solutions that work across the sector, simplify their workload, and benefit patients broadly. By bringing our solutions to the wider healthcare community, we can help build more unified approaches to how we all develop and deploy digital technologies, better serving our teams, physicians, and ultimately patients. Evinova represents a unique opportunity to deliver meaningful outcomes with digital and AI to serve the wider healthcare community and create new standards for the sector. Join us on our journey of building a new kind of health tech business to reset expectations of what a bio-pharmaceutical company can be. This means we're opening new ways to work, pioneering cutting-edge methods, and bringing unexpected teams together. Interested? Come and join our journey. At AstraZeneca, we're not just a pharmaceutical company - we're a healthcare provider beyond medicines. We're committed to using technology to better understand diseases, develop new medicines, and support patients with all aspects of their disease. We're digitally enabling the entire Research & Development cycle: improving clinical trials and data collection, developing digital therapeutics for rapid diagnostics, using machine learning and visual analytics for informed decision-making, integrating data to improve patient outcomes, and gaining insights to inform the next generation of products. Join us on our journey to create the future of medicine. Be empowered to act; explore and disrupt whilst working on the cutting-edge. If you thrive on adapting your skills and learning from failures, then this is the place for you. Ready to make a difference? Apply now! The annual base pay for this position ranges from $131,653.60 - 197,480.40. Hourly and salaried non-exempt employees will also be paid overtime pay when working qualifying overtime hours. Base pay offered may vary depending on multiple individualized factors, including market location, job-related knowledge, skills, and experience. In addition, our positions offer a short-term incentive bonus opportunity; eligibility to participate in our equity-based long-term incentive program (salaried roles), to receive a retirement contribution (hourly roles), and commission payment eligibility (sales roles). Benefits offered included a qualified retirement program [401(k) plan]; paid vacation and holidays; paid leaves; and, health benefits including medical, prescription drug, dental, and vision coverage in accordance with the terms and conditions of the applicable plans. Additional details of participation in these benefit plans will be provided if an employee receives an offer of employment. If hired, employee will be in an "at-will position" and the Company reserves the right to modify base pay (as well as any other discretionary payment or compensation program) at any time, including for reasons related to individual performance, Company or individual department/team performance, and market factors. Date Posted 28-Oct-2024 Closing Date 15-Dec-2024Our mission is to build an inclusive and equitable environment. We want people to feel they belong at AstraZeneca and Alexion, starting with our recruitment process. We welcome and consider applications from all qualified candidates, regardless of characteristics. We offer reasonable adjustments/accommodations to help all candidates to perform at their best. If you have a need for any adjustments/accommodations, please complete the section in the application form. AstraZeneca requires all US employees to be fully vaccinated for COVID-19 but will consider requests for reasonable accommodations as required by applicable law.

Created: 2024-10-31